The rising prevalence of end stage renal disease and surge in demand for home dialysis treatment are anticipated to drive the global peritoneal dialysis market, finds Fortune Business Insights in a new study. The study is titled “Peritoneal Dialysis Market: Global Market Analysis, Insights, and Forecasts, 2018 – 2025.” According to the study, the global peritoneal dialysis market will rise at 6.9% CAGR and reach a value of US$ 6,077.2 Mn by 2025 from US$ 3,589.9 Mn.
Asia Pacific to Emerge Dominant on Account of Better Growth Opportunities from Developed Nations
The number of people affected by renal problems is increasing by the day, especially in under developed or developing areas with limited access to healthcare facilities. The launch of awareness programs by governments of such nations are helping the market for peritoneal dialysis to gain more traction. The market in Asia Pacific is expected to rise at a faster rate due to the advent of new technology, and increasing number of healthcare and medical centers in the region. In 2017, Asia Pacific generated a revenue of US$ 1,194.1 Mn owing to the rising adoption of peritoneal dialysis in the developing nations of China and India. Government support and adequate reimbursement policies will help the market in the region to emerge dominant during the forecast period.
Major players are investing huge sums into research and development programs for the discovery of better therapeutic options. New product launches, mergers and acquisitions, and other strategies adopted by market players will help the market to generate more revenues in the near future. Some of the players operating in the global peritoneal dialysis market are Fresenius Kabi AG, Baxter, Medical Components, Inc., Cook Medical Inc., Glomeria Therapeutics, Medtronic, Fresenius Kabi AG, Utah Medical Products, Inc., Poly Medicure Ltd., and CardioMed Supplies Inc.
- Definitionsand Assumptions
Top Related [email protected]